Length of repeat variations in the androgen receptor gene and in the steroid nuclear receptor coactivator AIB1/NCOA3 were reported to affect breast cancer risk (reviewed in Narod, 2002a), but this has not been confirmed (Spurdle et al, 2005, 2006). This evidence concerns the gene NCOA3 and breast cancer.